MedPath

The effect of Yapana Basti, Shashti Shali Pinda Swedana and Nasya Karma in Amyotrophic Lateral Sclerosis (Vatavyadhi).

Phase 2
Conditions
Health Condition 1: G122- Motor neuron disease
Registration Number
CTRI/2024/05/067257
Lead Sponsor
ational Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

(a) Diagnosed cases of Amyotrophic Lateral Sclerosis, having less than five years onset.

(b) Patients will be selected from the age group of 20-60 years, irrespective of sex, religion

and occupation etc.

(c) Patients of ALS who are willing to participate in an interventional study.

(d) Patients willing to sign the informed consent form

Exclusion Criteria

(a) Patients with brain lesions.

(b) Patients with systemic or endocrine disorders.

(c) Patients with severe respiratory distress.

(d) Age less than 20 years and more than 60 years.

(e) Patients having other neurological degenerated diseases.

(f) Patients not willing to sign the informed consent form.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes will be assessed on the basis of the ALS Functional <br/ ><br>Rating Scale- Revised (ALSFRS-R) and Norris scale.Timepoint: Day 0 (Baseline), Day 30, and Day 75 (Follow-up)
Secondary Outcome Measures
NameTimeMethod
Relief in other symptoms of Amyotrophic Lateral Sclerosis.Timepoint: 75days
© Copyright 2025. All Rights Reserved by MedPath